Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 09-1998 | 06-1998 | 03-1998 | 12-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,450 | 4,750 | 4,660 | 4,430 | 4,430 |
| Marketable Securities | 2,520 | 2,370 | 2,010 | 2,340 | 2,340 |
| Receivables | 1,040 | 1,530 | 1,250 | 1,310 | 1,310 |
| Inventories | 1,220 | 1,340 | 1,400 | 1,480 | 1,480 |
| Other current assets | 660 | 590 | 630 | 450 | 450 |
| TOTAL | $9,890 | $10,580 | $9,950 | $10,010 | $10,010 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 230 | 250 | 280 | 300 | 300 |
| TOTAL | $230 | $250 | $280 | $300 | $300 |
| Total Assets | $10,920 | $11,660 | $11,090 | $11,190 | $11,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 920 | 1,250 | 960 | 1,310 | 1,310 |
| Other current liabilities | 170 | 170 | 170 | 170 | 170 |
| TOTAL | $1,320 | $1,560 | $1,240 | $1,550 | $1,550 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 250 | 240 | 220 | 220 | 220 |
| TOTAL | $250 | $240 | $220 | $220 | $220 |
| Total Liabilities | $1,570 | $1,810 | $1,460 | $1,770 | $1,770 |
| Shareholders' Equity | |||||
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | 7,230 | 7,000 | 6,650 | 6,420 | 6,420 |
| Other shareholders' equity | 445 | 175 | 315 | 385 | 385 |
| TOTAL | $9,350 | $9,850 | $9,620 | $9,420 | $9,420 |
| Total Liabilities And Equity | $10,920 | $11,660 | $11,080 | $11,190 | $11,190 |